title: Sorafenib- or 90Y-loaded resin microsphere radioembolization for locally advanced hepatocellular carcinoma, what should we trust?
authors.affiliation: Nuclear Medicine Department, Cancer Institute Eugène Marquis, Rennes, France.|University of Rennes 1, Rennes, France.|INSERM U991 Liver Metabolisms and Cancer, Rennes, France.
authors.forename: Etienne
authors.initials: E
authors.lastname: Garin
authors.affiliation: Interventional Radiology, Department, Cancer Institute Eugène Marquis, Rennes, France.
authors.forename: Yan
authors.initials: Y
authors.lastname: Rolland
authors.affiliation: University of Rennes 1, Rennes, France.|INSERM U991 Liver Metabolisms and Cancer, Rennes, France.|Digestive Oncology, Department, Cancer Institute Eugène Marquis, Rennes, France.
authors.forename: Julien
authors.initials: J
authors.lastname: Edeline
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006528:Carcinoma, Hepatocellular / Q000628:therapy*; D004621:Embolization, Therapeutic; D005260:Female; D006801:Humans; D008113:Liver Neoplasms / Q000628:therapy*; D008297:Male; D009536:Niacinamide / Q000031:analogs & derivatives*; D010671:Phenylurea Compounds / Q000627:therapeutic use*; D015021:Yttrium Radioisotopes / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D010671:Phenylurea Compounds; D015021:Yttrium Radioisotopes; D009536:Niacinamide